IFF's Leverage to Improve by 2025, Sales Momentum to Boost EBITDA, Projects Analyst
IFF's Leverage to Improve by 2025, Sales Momentum to Boost EBITDA, Projects Analyst
Stifel analyst Mark S. Astrachan upgraded International Flavors & Fragrances Inc. (NYSE:IFF) stock to Buy from Hold with an increased price target of $115 from $95.
Stifel的分析師Mark S. Astrachan將國際香料香精公司（NYSE:IFF）的股票評級從持有升級至買入，並將目標股價從95美元上調至115美元。
The analyst sees 2024 guidance as conservative and is increasing the sales and adjusted EBITDA forecasts for 2024-2025 by 1.5% and 4.4% above the company's top-end targets.
該分析師認爲，2024年公司預期中的指標過於保守，並將2024-2025年的銷售和調整後的EBITDA預測值上調了1.5%和4.4%，高於公司的指標。
IFF's volumes rebounded strongly in the first-quarter 2024, rising mid-single-digits after five quarters of decline, writes the analyst.
該分析師稱，IFF的銷量在2024年第一季度強勁反彈，連續5個季度下滑後，銷量增長了中單位數。
Also Read: IFF's Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst
此外：分析師稱，IFF關注健康和環保將推動股票的動力。
Astrachan expects mid-single-digit volume growth throughout 2024, driven by improved comparisons and a return to growth among many F&F customers in the second half of 2024.
Astrachan預計，在2024年的中期，單位銷量增長率將保持在中單位數，並由於第二季度開始很多食品和香料增長，而實現增長。
The analyst further adds that incremental sales are projected to have a ~30% contribution margin, potentially adding about $95 million to the midpoint of the company's adjusted EBITDA guidance, equating to a ~4%-5% increase.
該分析師進一步表示，預計增量銷售將有約30%的貢獻利潤，爲公司調整後的EBITDA指導方針中點增加約9500萬元，相當於4%-5%的增長。
Astrachan anticipates leverage will decrease to around 3.0x by year-end 2025, down from 4.7x at the end of the first quarter of 2024, primarily due to Pharma segment sales in the first half of 2025 and improving free cash flow.
Astrachan預計，由於2025年上半年藥品銷售和不斷增長的自由現金流，槓桿率將從2024年第一季度末的4.7倍降至年底的3.0倍左右。
The company expects to release the second quarter FY24 results on August 6, 2024.
該公司預計將於2024年8月6日發佈第二季度FY24的成果。
IFF stock has gained over 15% in the last 12 months. Investors can gain exposure to the stock via SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF (BATS:MVAL) and IShares Emergent Food And AgTech Multisector ETF (NASDAQ:IVEG).
IFF股票在過去的12個月中上漲了15%以上。投資者可以通過SHL Telemedicine Ltd VanEck Morningstar Wide Moat Value ETF（BATS：MVAL）和iShares Emergent Food And AgTech Multisector ETF（NASDAQ：IVEG）接觸該股票。
Price Action: IFF shares are up 2.78% at $98.33 at the last check Monday.
價格行動：IFF股票上漲2.78%，報98.33美元。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免責聲明：本內容部分使用人工智能工具生成，並經Benzinga編輯審核發佈。